(Total Views: 682)
Posted On: 10/17/2020 12:32:23 AM
Post# of 154078
Re: Goosebumps #61705
“I would expect Nader to not say anything nor could he. As for the comments on pathway.”
NP mentions nearly every single detail of behind the scenes action at CYDY but in this case he’s keeping quiet? We as investors have played this, “guess the CC,” game over and over since March. What we’ve learned is that the CC is never what we hope it will be (data reveal, FDA approval, uplisting announcement, licensing deals, etc.). The CCs are typically good updates with a few tid bits of new information. I don’t know why this one would be any different.
“Once again, Tuesday could still have a EUA if they wanted all talks private.”
What talks would be private? The DSMC recommends halting the trial for efficacy and then CYDY applies for EUA. NP would no doubt PR both of those events in a heart beat.
NP mentions nearly every single detail of behind the scenes action at CYDY but in this case he’s keeping quiet? We as investors have played this, “guess the CC,” game over and over since March. What we’ve learned is that the CC is never what we hope it will be (data reveal, FDA approval, uplisting announcement, licensing deals, etc.). The CCs are typically good updates with a few tid bits of new information. I don’t know why this one would be any different.
“Once again, Tuesday could still have a EUA if they wanted all talks private.”
What talks would be private? The DSMC recommends halting the trial for efficacy and then CYDY applies for EUA. NP would no doubt PR both of those events in a heart beat.
(6)
(0)
